Physician profile
Amber Glessner
NPI 1871068718
$3,429.43
in general payments reported to CMS, 2019-2025
12 companies · $1,634 in 2025
The $1,634 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $655 · 2022: $387 · 2023: $283 · 2024: $471 · 2025: $1,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,197 · Travel and Lodging: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,197.34 |
| Travel and Lodging | $190.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,838.15 | 2021-2025 | Venaseal, Abre, Closurefast |
| Tactile Systems Technology INC | $637.81 | 2021-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Janssen Pharmaceuticals, INC | $189.05 | 2021-2023 | Xarelto |
| Argenx US, INC. | $140.31 | 2025 | Vyvgart |
| Bioventus LLC | $132.20 | 2025 | Exogen Ultrasound Bone Healing System |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $103.20 | 2021 | |
| Sanofi-Aventis U.S. LLC | $97.56 | 2025 | |
| Lundbeck LLC | $96.86 | 2025 | Vyepti |
| Bsn Medical INC | $65.23 | 2024-2025 | |
| Boston Scientific Corporation | $62.69 | 2021-2025 | Varithena Administration Pack |
| Getinge USA Sales, LLC | $39.89 | 2023 | Cardioroot |
| Silk Road Medical, INC. | $26.48 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Glessner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.